Effects of Intranasal Oxytocin Administration on Social Influence Effects on Pain

Completed · Phase 1 · Has a placebo group

Conditions studied: Pain

In brief

This experiment will explore the joint effects of social information, social support, associative learning, and oxytocin on the development of placebo analgesia. The investigators predict that socially transmitted placebo effects will be enhanced by nasal administration of oxytocin, whereas associative learning effects on pain will not be altered by this pharmacological manipulation

Key facts

Study ID

NCT03060031

Run by

University of Colorado, Boulder

People needed

51

Starts

2017-06-21

Expected to finish

2019-04-01

Last updated by the study team

2019-06-25

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subject is a volunteer between 18 and 40 years of age.
• If female, subject is non-lactating, not pregnant, and using a reliable contraception method
• Subject is able to read and speak English.
• Subject is able and willing to provide written informed consent.
• Subject is able to understand and follow the instructions of the investigator and understand all screening questionnaires.
• Subject is in good health.
• For participants to be eligible for all tasks of the study, the participant must have a romantic partner and be willing to bring the partner to the study session.

You may not qualify if…

• Tests positive on the 14 panel poly-substance urine drug screen for illicit substances (e.g., marijuana (THC), cocaine (COC), phencyclidine (PCP), amphetamine (AMP), ecstasy (MDMA), methamphetamine (Mamp), opiates (OPI), oxycodone (OXY), methadone (MTD), barbiturates (BAR), benzodiazepines (BZO), buprenorphine (BUP), tricyclic antidepressants (TCA), propoxyphene (PPX))
• Chronic Pain
• Do not have the ability to tolerate heat pain applied to the forearm
• Have temporary abnormal levels of pain
• Have score of > 19 using the Center for Disease and Epidemiology Depression Scale
• Current treatment (e.g., medications or therapy) for psychiatric disorders, including mood, anxiety, substance abuse, Attention-deficit/hyperactivity disorder (ADHD), psychosis; Neurological disorders (e.g., taking dopamine agonists for Parkinson's); Cardiovascular disease or medication (e.g., taking ACE (angiotensin-converting-enzyme) inhibitors for cardiac remodeling)
• Frequent smoking (> 5 cigarettes / day); frequent alcohol use (>14 drinks / week); frequent migraines (> 5 / month on average) or a history of neurologic disease or neuropathic pain.
• Any allergy to Oxytocin

Where it is running

• Clinical Translational Research Center — Boulder, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.